How to Cite:
M E, Yavari
S. Cost-Effectiveness of Three Rounds of Mammography Breast Cancer Screening in Iranian Women,
Int J Cancer Manag.
Astim E. Cost-effectiveness analysis of a prospective breast cancer screening program in Turkey 2011;
Breast cancer in Iran: an epidemiological review.
Breast J. 2007; 13(4) : 383
Twenty years of breast cancer in Iran: downstaging without a formal screening program.
Ann Oncol. 2011; 22(1) : 93
Akbari ME, Haghighatkhah H, Shafiee M, Akbari A, Bahmanpoor M, Khayamzadeh M. Mammography and ultrasonography reports compared with tissue diagnosis--an evidence based study in Iran, 2010.
Asian Pac J Cancer Prev. 2012; 13(5) : 1907
Warner E. Clinical practice. Breast-cancer screening.
N Engl J Med. 2011; 365(11) : 1025
Barfar E, Rashidian A, Hosseini H, Nosratnejad S, Barooti E, Zendehdel K. Cost-effectiveness of mammography screening for breast cancer in a low socioeconomic group of Iranian women.
Arch Iran Med. 2014; 17(4) : 241
Barfar E, Rashidiyan A, Zendehdel AS. Cost-effectiveness of mammograghy breast Cancer screening in Vulnerable Household Women.
9. Breast cancer screening of ministry of health and medical education women staff 2002;
TETO . Breast cancer screening of Tehran cities female teachers. Tehran 2004;
11. Iran National Census of population and housing 2011;
12. Iranian annual cancer registration report 2012;
Wallis M, Neilson F, Hogarth H, Whitaker C, Faulkner K. Cumulative attendance, assessment and cancer detection rate over four screening rounds in five English breast-screening programmes: a retrospective study.
J Public Health (Oxf). 2007; 29(3) : 275
Vulnerable household women’s health assessment (VH-WHAT): protocol design and implementation.
IRCMJ. 2010; 2010(4) : 358
Haghighat S, Akbari ME, Ghaffari S, Yavari P. Standardized breast cancer mortality rate compared to the general female population of Iran.
Asian Pac J Cancer Prev. 2012; 13(11) : 5525
van Dijck JA,
Age at diagnosis and breast cancer survival in iran.
Int J Breast Cancer. 2012; 2012 : 517976
Akbari ME, Khayamzadeh M, Khoshnevis SJ, Nafisi N, Akbari A. Five and ten years survival in breast cancer patients mastectomies vs. breast conserving surgeries personal experience.
IJCP. 2012; 1(2) : 53
Saeedi Saedi H, Ghavam Nasiri MR, ShahidSales S, Taghizadeh A, Mohammadian N. Comparison of hormone receptor status in primary and recurrent breast cancer.
Iran J Cancer Prev. 2012; 5(2) : 69
Wong IO, Kuntz KM, Cowling BJ, Lam CL, Leung GM. Cost effectiveness of mammography screening for Chinese women.
Cancer. 2007; 110(4) : 885
21. Iranian annual report of death registration 2006 deputy for health 2007;
Survival rate of breast cancer based on geographical variation in iran, a national study.
Iran Red Crescent Med J. 2012; 14(12) : 798
23. Tarrif of diagnistic and therapeutic services 2012;
Tan-Torres Edejer T,
Making choices in health: WHO guide to cost-effectiveness analysis 2003;
25. Cost-effectiveness thresholds ,. 2013;
Whelehan P, Evans A, Wells M, Macgillivray S. The effect of mammography pain on repeat participation in breast cancer screening: a systematic review.
Breast. 2013; 22(4) : 389
Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials.
The Lancet. 2002; 359(9310) : 909
Decreasing incidence of late-stage breast cancer after the introduction of organized mammography screening in Italy.
Cancer. 2013; 119(11) : 2022
van den Akker‐van Marle ME, Reep‐van den Bergh CMM, Boer R, Del Moral A, Ascunce N, de Koning HJ. Breast cancer screening in Navarra: interpretation of a high detection rate at the first screening round and a low rate at the second round.
Int J Cancer. 1997; 73(4) : 464
Results from 10 years of breast screening in Wales.
J Med Screen. 2001; 8(1) : 21
Heydari S, Mehrabani D, Tabei SZ, Azarpira N, Vakili MA. Survival of breast cancer in southern Iran.
IJCP. 2012; 2(1) : 51
Salzmann P, Kerlikowske K, Phillips K. Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age.
Ann Intern Med. 1997; 127(11) : 955
Ross A, Salzmann M, Senn H. Fast-HMQC using Ernst angle pulses: An efficient tool for screening of ligand binding to target proteins.
J Biomol NMR. 1997; 10(4) : 389
Okonkwo QL, Draisma G, der Kinderen A, Brown ML, de Koning HJ. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
J Natl Cancer Inst. 2008; 100(18) : 1290
Coldman A, Phillips N. Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program.
Can Med Assoc J . 2013; 185(10) -8
Prasad V, Lenzer J, Newman DH. Why cancer screening has never been shown to "save lives"-and what we can do about it.
BMJ. 2016; 352[DOI][PubMed]
Gotzsche PC, Jorgensen KJ, Gotzsche PC. Screening for breast cancer with mammography.
Lidgren M, Wilking N, Jonsson B. Cost of breast cancer in Sweden in 2002.
Eur J Health Econ. 2007; 8(1) : 5